US Patent Issued to FBD Biologics on Oct. 21 for "Engineered SIRPAlpha variants and methods of use thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,195, issued on Oct. 21, was assigned to FBD Biologics Ltd. (Kowloon, Hong Kong).

"Engineered SIRPAlpha variants and methods of use thereof" was invented by Jiin-Tarng Wang (Taichung, Taiwan), Han-Fang Teng (New Taipei, Taiwan), Pan-Hsien Kuo (Taoyuan, Taiwan), Chi-Ling Tseng (Taipei, Taiwan) and Zong Sean Juo (New Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to engineered SIRPAlpha variants, and methods of use thereof."

The patent was filed on Oct. 31, 2023, under Application No. 18/498,843.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...